Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(11 sites)
United Kingdom
Queen Elizabeth Hospital, Birmingham Addenbrooke's Hospital, Cambridge Western General Hospital, Edinburgh Beatson West of Scotland Cancer Centre, Glasgow St James's Hospital, Leeds Clatterbridge Cancer Centre, Liverpool Hammersmith Hospital, London King's College Hospital, London Royal Free Hospital, London The Christie NHS Foundation Trust, Manchester Freeman Hospital, Newcastle upon Tyne Last updated December 2024